Activation of the tissue kallikrein-kinin system in stroke - PubMed (original) (raw)
Activation of the tissue kallikrein-kinin system in stroke
Simone Wagner et al. J Neurol Sci. 2002.
Abstract
Edema formation is a major problem in large ischemic infarcts, and the underlying breakdown of the blood-brain barrier is only incompletely understood. Here, we report that the tissue kallikrein-kinin system, which influences the permeability of the blood-brain barrier, is activated in stroke. In 22 patients with large infarcts in the territory of the middle cerebral artery, we found elevated plasma concentrations of the tissue kinin kallidin. The data suggest that further studies on a possible role of kinin receptor antagonists on edema after stroke are warranted.
Copyright 2002 Elsevier Science B.V.
Similar articles
- The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
Marcondes S, Antunes E. Marcondes S, et al. Curr Med Chem Cardiovasc Hematol Agents. 2005 Jan;3(1):33-44. doi: 10.2174/1568016052773351. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 15638742 Review. - Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
Hilgenfeldt U, Puschner T, Riester U, Finsterle J, Hilgenfeldt J, Ritz E. Hilgenfeldt U, et al. Am J Physiol. 1998 Jul;275(1):F88-93. doi: 10.1152/ajprenal.1998.275.1.F88. Am J Physiol. 1998. PMID: 9689009 - Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans.
Campbell DJ, Dixon B, Kladis A, Kemme M, Santamaria JD. Campbell DJ, et al. Am J Physiol Regul Integr Comp Physiol. 2001 Oct;281(4):R1059-70. doi: 10.1152/ajpregu.2001.281.4.R1059. Am J Physiol Regul Integr Comp Physiol. 2001. PMID: 11557611 - The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
Chao J, Bledsoe G, Yin H, Chao L. Chao J, et al. Biol Chem. 2006 Jun;387(6):665-75. doi: 10.1515/BC.2006.085. Biol Chem. 2006. PMID: 16800727 Review. - Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
Devani M, Cugno M, Vecchi M, Ferrero S, Di Berardino F, Avesani EC, de Franchis R, Colman RW. Devani M, et al. Am J Gastroenterol. 2002 Aug;97(8):2026-32. doi: 10.1111/j.1572-0241.2002.05919.x. Am J Gastroenterol. 2002. PMID: 12190172
Cited by
- Remodeling of motor cortex function in acute cerebral infarction patients following human urinary kallidinogenase: A functional magnetic resonance imaging evaluation after 6 months.
Song X, Han L, Liu Y. Song X, et al. Neural Regen Res. 2012 Apr 15;7(11):867-73. doi: 10.3969/j.issn.1673-5374.2012.11.012. Neural Regen Res. 2012. PMID: 25737716 Free PMC article. - Candidate-based proteomics in the search for biomarkers of cardiovascular disease.
Anderson L. Anderson L. J Physiol. 2005 Feb 15;563(Pt 1):23-60. doi: 10.1113/jphysiol.2004.080473. Epub 2004 Dec 20. J Physiol. 2005. PMID: 15611012 Free PMC article. Review. - TRPV1 activation results in disruption of the blood-brain barrier in the rat.
Hu DE, Easton AS, Fraser PA. Hu DE, et al. Br J Pharmacol. 2005 Oct;146(4):576-84. doi: 10.1038/sj.bjp.0706350. Br J Pharmacol. 2005. PMID: 16056236 Free PMC article. - Involvement of bradykinin in brain edema development after ischemic stroke.
Dobrivojević M, Špiranec K, Sinđić A. Dobrivojević M, et al. Pflugers Arch. 2015 Feb;467(2):201-12. doi: 10.1007/s00424-014-1519-x. Epub 2014 Apr 23. Pflugers Arch. 2015. PMID: 24756199 Review. - The temporal dynamic of bradykinin type 2 receptor effects reveals its neuroprotective role in the chronic phase of cerebral and retinal ischemic injury.
Justić H, Barić A, Ratko M, Šimunić I, Radmilović M, Pongrac M, Škokić S, Dobrivojević Radmilović M. Justić H, et al. J Cereb Blood Flow Metab. 2025 Jan;45(1):153-170. doi: 10.1177/0271678X241270241. Epub 2024 Aug 7. J Cereb Blood Flow Metab. 2025. PMID: 39113417 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources